Most medical devices in the United States come to market with limited clinical data, and device surveillance is viewed as a ...

Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital ...

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a ...

Pfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big ...

In ongoing trials of Eli Lilly’s next-generation obesity drug, several trial participants are running into an issue they never expected: They are losing too much weight. One participant lost 22% ...

Signal transducer and activator of transcription 6 (STAT6) is a member of the STAT family involved in the regulation of ... Researchers from Recludix Pharma Inc. have presented the preclinical ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

Pharmaceutical companies are developing new weight-loss treatments that aim to shed the pounds while preserving muscle mass -- a downside of current drugs. (Reuters via MSN) In a phase Ib trial, ...